23rd October 2023
Enabling the fastest & most economical unbiased hit identification
Serengen synthesises and screens DNA-Encoded Libraries (DEL) tailored to your project.
Our proprietary technology offers the fastest and most cost-efficient approach to hit identification that allows for serendipity and delivers high quality hits.
Accelerate early drug discovery
Perform today’s fastest and most economical hit identification and significantly speed up early drug discovery:
PHARMA
Access a unique DEL technology that allows to add a truly novel chemical space to your DEL screening decks.
BIOTECH
Benefit from serendipity in hit ID with a breakthrough DEL technology that offers lower hit attrition and lower follow-up costs.
START-UPS & RESEARCH ORGANISATIONS
Save time and budget by screening DELs that are designed for your target proteins.
Talk to us about flexible business models!
What´s new
Deargen and Serengen Partner to Accelerate Drug Discovery
Get ready to take hit ID in drug discovery to the next level! Serengen and Deargen have partnered up to integrate their DEL and AI platforms for a faster, more affordable and effective drug discovery.
29th August 2023
Talk to
our experts!
our experts!
+49 (0)231 999 50 902
Contact us for a brainstorming session.
We are happy to answer any question!
We are happy to answer any question!
Talk to
our experts!
our experts!
+49 (0)231 999 50 902
Contact us for a brainstorming session.
We are happy to answer any question!
We are happy to answer any question!
*Required
I agree that the information I supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679.